Clínica Baviera, S.A. (CBAV.MC)

Clínica Baviera, S.A. (CBAV.MC) — VMCI valuation read

CBAV.MC prints VMCI 60/100 inside the Healthcare sector, where the median sits at 50. The 10-point above-median delta is the cleanest single-number summary of Clínica Baviera, S.A.'s composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.

On CBAV.MC, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** CBAV.MC trades at 16.0x earnings, 11% below the Healthcare median of 18.0x; that is the value line. ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 2.6x is the rate-sensitivity line to watch; that is the risk line for Clínica Baviera, S.A. on the trailing financials.

CBAV.MC fell 1.4% over the trailing 7 days, with a +2.0% read on a 30-day basis.